Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pa Shun International HoldingsHKSE:00574 EV-to-FCF is -7.44 as of Aug. 20, 2026. The stock has 9 warning signs investors should review. Among 409 Healthcare Providers & Services companies, Pa Shun International Holdings ranks worse than 244498.53% on this metric.
The historical rank and industry rank for Pa Shun International Holdings's EV-to-FCF or its related term are showing as below:
HKSE:00574'
s EV-to-FCF Range Over the Past 10 Years
Min: -80.34 Med: -9.5 Max: -2.41
Current: -7.44
During the past 13 years, the highest EV-to-FCF of Pa Shun International Holdings was -2.41. The lowest was -80.34. And the median was -9.50.
HKSE:00574's EV-to-FCF is ranked worse than 100% of 409
companies
in the Healthcare Providers & Services industry
Industry Median: 18.76
vs HKSE:00574: -7.44
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Pa Shun International Holdings (HKSE:00574) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Pa Shun International Holdings's PE Ratio (TTM) for today is calculated as:
Pa Shun International Holdings's share price for today is HK$0.018.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pa Shun International Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.009.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Pa Shun International Holdings EV-to-FCF Related Terms
Pa Shun International Holdings EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pa Shun International Holdings EV-to-FCF Competitor Comparison
For the Pharmaceutical Retailers subindustry, Pa Shun International Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pa Shun International Holdings EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pa Shun International Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Pa Shun International Holdings's EV-to-FCF falls into.
Pa Shun International Holdings's current Enterprise Value is HK$82.30 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pa Shun International Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-11.06 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pa Shun International Holdings (HKSE:00574) has a EV-to-FCF of -7.44 as of Aug. 20, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Pa Shun International Holdings and its competitors. According to the industry distribution chart, Pa Shun International Holdings ranks #999999 out of 409 companies in the Healthcare Providers & Services industry.
Is Pa Shun International Holdings' EV-to-FCF too high?
Pa Shun International Holdings' current EV-to-FCF is -7.44. Based on the distribution chart, Pa Shun International Holdings ranks #999999 out of 409 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Pa Shun International Holdings' EV-to-FCF compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Pa Shun International Holdings ranks #999999 out of 409 companies for EV-to-FCF. This places Pa Shun International Holdings in the lower half of its industry. The industry median EV-to-FCF is 18.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.76, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Pa Shun International Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pa Shun International Holdings's current EV-to-FCF is -7.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pa Shun International Holdings stock overvalued right now?
Based on GuruFocus' analysis, Pa Shun International Holdings (HKSE:00574) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.03, compared to a current price of HK$0.02 — trading 40% below its estimated fair value. The current EV-to-FCF is -7.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Pa Shun International Holdings (HKSE:00574), the current EV-to-FCF is -7.44 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pa Shun International Holdings Ltd is an investment holding company engaged in the manufacturing and distribution of pharmaceutical products. The business activity of the group is operated through Pharmaceutical distribution and Pharmaceutical manufacturing segment. Geographically all the activities are carried out in the PRC. The company derives the majority of revenue from the Pharmaceutical distribution segment which include sales of pharmaceutical products to wholesalers, franchise retail pharmacy chain stores and hospitals and other medical institutions in rural areas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00574 has been successfully added to your 
